Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 261 - Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
Patents for C07D 261 - Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings (11,459)
10/2005
10/20/2005US20050234061 N-[3-(4-chlorophenyl)-2-(3-pyridyl)-1-methylpropyl]-2-(5-trifluoromethyl-2-pyridyloxy)-2-methylpropanamide; obesity; antipsychotic agents; synergistic; cannabinoid receptor antagonists
10/20/2005CA2561791A1 Non-imidazole heterocyclic compounds
10/20/2005CA2559866A1 Anaplastic lymphoma kinase modulators and methods of use
10/19/2005EP1586559A1 Biaryl-methanethio-, -sulphinyl- and sulphonyl derivatives
10/19/2005EP1585739A1 Substituted arylcyclopropylacetamides as glucokinase activators
10/19/2005EP1585733A1 Heterocyclic ppar modulators
10/19/2005CN1223348C N-(aryloxy group alkyl) heteroaromatic guadine and heteroaromatic guazine used as medicines
10/13/2005WO2005095361A1 Isoxazole- and isothiazole-amine compounds for the treatment of neurodegenerative disorders
10/13/2005WO2005095343A1 Dpp-iv inhibitors
10/13/2005WO2005094810A2 Novel pharmaceutical compositions
10/13/2005WO2005094329A2 Compouns, compositions, processes of making, and methods of use related to inhibiting macrophage migration inhibitory factor
10/13/2005WO2005021536A3 Adamantane and azabicyclo-octane and nonane derivatives, process of their preparation and their use as dpp-iv inhibitors
10/13/2005US20050227987 11beta-hydroxysteroid dehydrogenase inhibitors
10/13/2005US20050227914 hydrolysis of methyl 4-[5-(4-pentyloxyphenyl)isoxazol-3-yl]benzoate with potassium hydroxide, then reacting the potassium salt with hydrochloric acid, to form 4-[5-(4-pentyloxyphenyl)isoxazol-3-yl]benzoic acid, used as intermediates for peptide antibiotics; echinocandin derivatives
10/13/2005CA2562700A1 Novel pharmaceutical compositions
10/13/2005CA2562106A1 Isoxazole- and isothiazole-amine compounds for the treatment of neurodegenerative disorders
10/13/2005CA2558446A1 Dpp-iv inhibitors
10/13/2005CA2557166A1 Compounds, compositions, processes of making, and methods of use related to inhibiting macrophage migration inhibitory factor
10/12/2005EP1583972A2 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions
10/12/2005EP1583748A1 Process for the preparation of 1,2-dichloroethane free crystals of zonisamide and the highly pure crystals of zonisamide
10/12/2005EP1583746A1 A pyrazole derivative as ppar modulator
10/12/2005EP1482939A4 Preparation of paroxetine involving novel intermediates
10/12/2005CN1681557A Methods for treating carbonic anhydrase mediated disorders
10/12/2005CN1679556A Valdecoxib compositions
10/06/2005WO2005092869A1 One-pot process for producing 1,2-benzisoxazole-3-methanesulfonamide
10/06/2005WO2005092836A1 Opioid receptor antagonists
10/06/2005WO2005092316A1 Novel pharmaceutical compositions comprising agonists of the thyroid receptor
10/06/2005WO2005092011A2 Mitotic kinesin inhibitors
10/06/2005US20050222423 Carboxylic acid derivative
10/06/2005US20050222151 Non-Imidazole heterocyclic compounds
10/06/2005US20050222149 For therapy of neurodegenerative and/or neurological disorders, e.g., Alzheimer's disease, in a mammal
10/06/2005US20050222146 N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof
10/06/2005CA2560526A1 Novel pharmaceutical compositions comprising agonists of the thyroid receptor
10/06/2005CA2560213A1 Mitotic kinesin inhibitors
10/06/2005CA2557794A1 Opioid receptor antagonists
10/05/2005EP1581516A2 3-heterocyclic benzylamide derivatives as potassium channel openers
10/05/2005EP1581508A1 A process for the preparation of benzo d isoxazol-3-yl- methanesulfonic acid and the intermediates thereof
10/05/2005EP1581496A2 2-substituted-3-propenamide derivatives and methods of using the same
10/05/2005EP1581488A1 Inhibitors of tace
10/05/2005EP1296965B1 Method for producing 4-bromine-aniline derivatives
10/05/2005EP1183233B1 Bradykinin receptor antagonists
10/05/2005CN1678372A Heterocyclic aromatic compounds useful as growth hormone secretagogues
10/05/2005CN1221526C Novel phenyl-propargyl ether derivatives
10/04/2005US6951945 Heteroaromatic glucokinase activators
10/04/2005US6951878 Benzo[b]thiophenyl or tetrahydro-benzo[b]thiophenyl modulators of protein tyrosine phosphatases (PTPases)
09/2005
09/29/2005WO2005090322A1 Derivatives of alkylpiperazine- and alkylhomopiperazine- carboxylates, preparation method thereof and use of same as faah enzyme inhibitors
09/29/2005WO2005090292A1 Derivatives of heteroaryl-alkylcarbamates, preparation method thereof and use of same as faah enzyme inhibitors
09/29/2005WO2005089753A2 Daao inhibiting bξnzisoxazoles and their use for the treatment of mental disorders
09/29/2005US20050215796 without isolation of intermediates in solid form, by using 4-hydroxycoumarin and hydroxylamine as starting compounds, and water and 1,2-dichloroethane as solvents; preparation of the 1,2-benzisoxazole-3-acetic acid intermediate
09/29/2005CA2559105A1 Benzisoxazoles
09/29/2005CA2554855A1 Derivatives of alkylpiperazine- and alkylhomopiperazine- carboxylates, preparation method thereof and use of same as faah enzyme inhibitors
09/29/2005CA2554609A1 Derivatives of heteroaryl-alkylcarbamates, preparation method thereof and use of same as faah enzyme inhibitors
09/28/2005EP1578721A2 Processes for the preparation of substituted isoxazoles and 2-isoxazolines
09/28/2005EP1578715A2 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation
09/28/2005CN1673221A Isoxazoline derivative and herbicide comprising the same as active ingredient
09/27/2005US6949567 Asymmetric amidine-substituted diphenylureas; diseases treated by the inhibition of intracellular protein degradation pathways, e.g. proteases, proteasome; anticarcinogenic agents; immunological modulators
09/27/2005US6949556 For producing drugs used for therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, Prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction, stroke, thrombosis
09/22/2005WO2005087710A1 Aminophenylpropanoic acid derivative
09/22/2005WO2005087215A1 Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors
09/22/2005WO2005023759A3 Heterocyclic inhibitors of mek and methods of use thereof
09/22/2005CA2560111A1 Aminophenylpropanoic acid derivative
09/22/2005CA2558249A1 Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors
09/21/2005EP1575919A1 Phenyl or heteroaryl amino alkane derivatives as ip receptor antagonist
09/21/2005EP1294679B1 Beta-amino acid nitrile derivatives
09/21/2005CN1219753C Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids
09/21/2005CN1219510C Benzimidazole derivatives as modulators of IgE
09/20/2005US6946466 Aromatic sulfonamides as peroxynitrite-rearrangement catalysts
09/20/2005US6946462 N-monoacylated derivatives of o-phenylenediamines, their analogs and their use as pharmaceutical agents
09/15/2005WO2005085217A1 Polycyclic compound and process for producing the same
09/15/2005WO2005085216A1 Isoxazoline-substituted benzamide compound and noxious organism control agent
09/15/2005WO2005054204A3 Pharmaceutical compounds that regenerate in vivo
09/15/2005WO2005049589A3 Heterocyclic compounds for the treatment of hyperlipidemia, diabetes, obesity and similar diseases
09/15/2005US20050203149 Alkanamide alpha-monohydrazone derivatives, e.g., N-(4-chlorobenzyl)-2-(4-trifluoromethylphenylhydrazono)propionamide, for agricultural and horticultural use, clothing, food and housing-related use, or livestock and pet use
09/15/2005US20050203135 Modulating adhesion between intracellular adhesion molecules (e.g. ICAM-1, -2 and -3) and the leukocyte integrin family of receptors; inflammatory disorders, allergies, and autoimmune diseases such as psoriasis, rheumatoid arthritis, asthma, multiple sclerosis, transplant rejection
09/15/2005CA2558848A1 Isoxazoline-substituted benzamide compound and pesticide
09/14/2005EP1572612A1 Dihalo-allyloxy-phenol derivatives having pesticidal activity
09/14/2005EP1572127A2 Enzyme treatment of foodstuffs for celiac sprue
09/14/2005EP1572068A2 Arylheteroalkalylamine derivatives and their use as inhibitors of nitric oxide synthase
09/14/2005CN1668605A Broadspectrum substituted benzisoxazole sulfonamide HIV protease inhibitors
09/14/2005CN1668299A Methods for using JNK inhibitors for treating or preventing disease-related wasting
09/09/2005WO2005082871A2 Guanidine compounds, and use thereof as binding partners for 5-ht5 receptors
09/09/2005WO2005058884A3 Cyclopropane compounds and pharmaceutical use thereof
09/08/2005US20050197371 Urea derivatives as PDGFR modulators
09/07/2005EP1569920A2 Cyclopenta c]isoxazole-3-amines used as protective agents for materials
09/07/2005EP1569916A1 Substituted aralkyl derivatives
09/07/2005EP1569647A2 Cyclohexyl compounds as ccr5 antagonists
09/07/2005CN1665792A Aryl- and heteroarylcarbonylpiperazines and their use for the treatment of benign and malignant oncoses
09/07/2005CN1665780A Tricyclic steroid hormone nuclear receptor modulators
09/07/2005CN1217933C Dihalopropene compound, insecticide/miticide containing the same and intermediate for producing the same
09/07/2005CN1217932C Antibacterial agents
09/06/2005US6939875 Carbocyclic oxy sulfides such as [4-(Biphenyl-4-ylmethylsulfanyl)-5-methoxy-2-methyl-phenoxy]-acetic acid, used to control peroxisome proliferator activated receptors (PPAR), for prophylaxis of metabolic disorders
09/01/2005WO2005080344A1 Substituted azole compounds and thereof preparation and application
09/01/2005WO2005037271A3 Large conductance calcium-activated k channel opener
09/01/2005US20050192347 Urea and thiourea compounds and compositions for cholesterol management and related uses
09/01/2005US20050192314 Use of urea derivatives of isoxazoles; c-kit kinase inhibitors; anticancer agents; leukemias such as acute myelogenous leukemia (AML), and chronic myelogenous leukemias (CMLs)
09/01/2005US20050192313 Thio substituted with a hetero multiring group; sleepiness, promotion of wakefulness, Parkinson's disease, cerebral ischemia, stroke, sleep apneas, eating disorders, stimulation of appetite and weight gain, attention deficit hyperactivity disorder
09/01/2005DE102004008141A1 Guanidinverbindungen und ihre Verwendung als Bindungspartner für 5-HT5-Rezeptoren Guanidine compounds and their use as binding partners for 5-HT5 receptors
08/2005
08/31/2005EP1568367A1 Compounds effecting glucokinase
08/31/2005EP1140809B1 New biphenyl and biphenyl-analogous compounds as integrin antagonists
08/31/2005CN1660815A Cyclic amine derivatives and their use as drugs
1 ... 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 ... 115